Abstract
Human aromatase enzyme is a microsomal cytochrome P450 and catalyzes aromatization of androgens into estrogens during steroidogenesis. For breast cancer therapy, third-generation aromatase inhibitors (AIs) have proven to be effective; however patients acquire resistance to current AIs. Thus there is a need to predict aromatase-related proteins to develop efficacious AIs. A machine learning method was established to identify aromatase-related proteins using a five-fold cross validation technique. In this study, different SVM approach-based models were built using the following approaches like amino acid, dipeptide composition, hybrid and evolutionary profiles in the form of position-specific scoring matrix (PSSM); with maximum accuracy of 87.42%, 84.05%, 85.12%, and 92.02% respectively. Based on the primary sequence, the developed method is highly accurate to predict the aromatase-related proteins. Prediction scores graphs were developed using the known dataset to check the performance of the method. Based on the approach described above, a webserver for predicting aromatase-related proteins from primary sequence data was developed and implemented athttps://bioinfo.imtech.res.in/servers/muthu/aromatase/home.html. We hope that the developed method will be useful for aromatase protein related research.
Publisher
Public Library of Science (PLoS)
Reference82 articles.
1. Cancer Statistics, 2021;RL Siegel;CA: A Cancer Journal for Clinicians,2021
2. A Scoping Review on the Status of Female Breast Cancer in Asia with a Special Focus on Nepal;R Dhakal;Breast Cancer (Dove Med Press),2022
3. The role of local estrogen biosynthesis in males and females;E Simpson;Trends Endocrinol Metab,2000
4. Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging;F Labrie;J Clin Endocrinol Metab,1997
5. Estrogen and its metabolites are carcinogenic agents in human breast epithelial cells;J Russo;J Steroid Biochem Mol Biol,2003